What You Should Know:
- Sonde Health, a Boston, MA-based health technology company committed to bringing accessible health monitoring to everyone raises $19.25 million in a Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures.
- The AI vocal biomarker company will use the funding to accelerate its commercial growth, expand its platform into new health
Read More
Sonde Health
Sonde Health Launches Vocal Biomarker Tech to Monitor Mental Health and Well-Being
What You Should Know:
- Sonde Health has unveiled Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology that uses a brief voice sample to evaluate mental well-being. Available as an application programming interface (API) for health systems, employers, and wellness service providers, Sonde Mental Fitness is an easy and affordable way for individuals to engage with and better understand their mental well-being and can serve as a much-needed early warning
Read More
Sonde Health Acquires NeuroLex Lab’s Voice-Based Survey Platform
What You Should Know:
- Sonde Health acquires NeuroLex Laboratories, Inc. to forms
one of the world’s preeminent biobanks focused on vocal biomarkers.
- NeuroLex’s core product, SurveyLex, makes it easy to
create and distribute voice surveys in less than a minute as URL links through
web browsers.
Sonde Health, a
Boston-based digital vocal biomarker technology platform announced it has acquired
NeuroLex Laboratories, Inc., a leading
voice-enabled survey and data acquisition platform.
Read More
Sonde Health Nabs $16M to Commercialize Vocal Biomarker Device to Diagnose Diseases
Sonde Health, a Boston-based digital medicine company developing a vocal biomarker device to transform the way we monitor and diagnose our mental and physical health has raised $16 million in Series A funding. The round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany), with participation from MP Healthcare Venture Management, Inc. (the corporate venture capital arm of Mitsubishi Tanabe Pharma Corporation), Neoteny 4, LP, Canepa Healthcare, and founder
Read More
